DNA Methylation-Mediated GPX4 Transcriptional Repression and Osteoblast Ferroptosis Promote Titanium Particle-Induced Osteolysis
Open Access
- 1 January 2024
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Research
- Vol. 7, 0457
Abstract
Metal wear particles generated by the movement of joint prostheses inevitably lead to aseptic osteolytic damage and ultimately prosthesis loosening, which are aggravated by various types of regulated cell death of bone. Nevertheless, the exact cellular nature and regulatory network underlying osteoferroptosis are poorly understood. Here, we report that titanium particles (TP) induced severe peri-implant osteolysis and ferroptotic changes with concomitant transcriptional repression of a key anti-ferroptosis factor, GPX4, in a mouse model of calvarial osteolysis. GPX4 repression was accompanied by an increase in DNA methyltransferases (DNMTs) 1/3a/3b and hypermethylation of the Gpx4 promoter, which were partly mediated by the transcriptional regulator/co-repressor KLF5 and NCoR. Conversely, treatment with SGI-1027, a DNMT-specific inhibitor, resulted in marked reversal of Gpx4 promoter hypermethylation and GPX4 repression, as well as improvement in ferroptotic osteolysis to a similar extent as with a ferroptosis inhibitor, liproxstatin-1. This suggests that epigenetic GPX4 repression and ferroptosis caused by the increase of DNMT1/3a/3b have a causal influence on TP-induced osteolysis. In cultured primary osteoblasts and osteoclasts, GPX4 repression and ferroptotic changes were observed primarily in osteoblasts that were alleviated by SGI-1027 in a GPX4 inactivation-sensitive manner. Furthermore, we developed a mouse strain with Gpx4 haplodeficiency in osteoblasts ( Gpx4 Ob+/− ) that exhibited worsened ferroptotic osteolysis in control and TP-treated calvaria and largely abolished the anti-ferroptosis and osteoprotective effects of SGI-1027. Taken together, our results demonstrate that DNMT1/3a/3b elevation, resulting GPX4 repression, and osteoblastic ferroptosis form a critical epigenetic pathway that significantly contributes to TP-induced osteolysis, and that targeting DNMT aberration and the associated osteoferroptosis could be a potential strategy to prevent or slow down prosthesis-related osteolytic complications.Keywords
Funding Information
- National Natural Science Foundation of China (92368201)
- National Natural Science Foundation of China (81991514)
- National Natural Science Foundation of China (81970577)
- Ministry of Science and Technology of the People's Republic of China (2021YFA1201404)
This publication has 55 references indexed in Scilit:
- GPX4: The hub of lipid oxidation, ferroptosis, disease and treatmentBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2023
- NRF2 is a critical regulator and therapeutic target of metal implant particle-incurred bone damageBiomaterials, 2022
- Mitochondrial Ferritin Deficiency Promotes Osteoblastic Ferroptosis Via Mitophagy in Type 2 Diabetic OsteoporosisBiological Trace Element Research, 2021
- Reactive oxygen/nitrogen species (ROS/RNS) and oxidative stress in arthroplastyJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2020
- Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and DiseaseCell, 2017
- KLF5 overexpression attenuates cardiomyocyte inflammation induced by oxygen-glucose deprivation/reperfusion through the PPARγ/PGC-1α/TNF-α signaling pathwayBiomedicine & Pharmacotherapy, 2016
- More is better: Combination therapies for myelodysplastic syndromesBest Practice & Research Clinical Haematology, 2015
- Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiationFree Radical Biology and Medicine, 2013
- Osteolysis around total knee arthroplasty: A review of pathogenetic mechanismsActa Biomaterialia, 2013
- Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-κBBiochemical and Biophysical Research Communications, 2004